SincoƱegue, Rogelio .
HRN: 25-85-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/13/2024
09/20/2024
IV
4.5
Q8H
Pneumonia
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes